Relationship between anthropometric measures and the risk of incident Metabolic dysfunction-associated steatotic liver disease: a longitudinal study

被引：0
|
作者：
Takahiro Ichikawa [1 ]
Yoshitaka Hashimoto [1 ]
Takuro Okamura [2 ]
Akihiro Obora [1 ]
Takao Kojima [3 ]
Hiroshi Okada [3 ]
Masahide Hamaguchi [1 ]
Michiaki Fukui [1 ]
机构：
[1] Kyoto Prefectural University of Medicine,Department of Endocrinology and Metabolism, Graduate School of Medical Science
[2] Matsushita Memorial Hospital,Department of Diabetes and Endocrinology
[3] Asahi University Hospital,Department of Gastroenterology
来源：
BMC Gastroenterology | / 25卷 / 1期
关键词：
Anthropometric measure; MASLD; Japan; Cohort;
D O I：
10.1186/s12876-025-03780-8
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Incident cardiac arrhythmias associated with metabolic dysfunction-associated steatotic liver disease: a nationwide histology cohort study
    Simon, Tracey G.
    Ebrahimi, Fahim
    Roelstraete, Bjorn
    Hagstrom, Hannes
    Sundstrom, Johan
    Ludvigsson, Jonas F.
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [22] From metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease: Controversy and consensus
    Chen, Li
    WORLD JOURNAL OF HEPATOLOGY, 2023, 15 (12) : 1253 - 1257
  • [23] Causal relationship between depression and metabolic dysfunction-associated steatotic liver disease: a bidirectional Mendelian randomized study
    Liang, Weiyu
    Zhong, Kunting
    Lai, Tingting
    Zeng, Yuhao
    Huang, Zhanhui
    Zhou, Jiqing
    Huang, Jin
    Shi, Zhenni
    Zhang, Jin
    Ding, Fuping
    FRONTIERS IN PSYCHIATRY, 2024, 15
  • [24] Different Associations of Coffee Consumption with the Risk of Incident Metabolic Dysfunction-Associated Steatotic Liver Disease and Advanced Liver Fibrosis
    Lee, Jun-Hyuk
    Park, Jooyong
    Ahn, Sang Bong
    NUTRIENTS, 2024, 16 (01)
  • [25] Management of cardiovascular risk in patients with metabolic dysfunction-associated steatotic liver disease
    Mellemkjaer, Anders
    Kjaer, Mikkel Breinholt
    Haldrup, David
    Gronbaek, Henning
    Thomsen, Karen Louise
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 122 : 28 - 34
  • [26] Metabolic dysfunction-associated steatotic liver disease, liver fibrosis and risk of cardiovascular disease: A prospective cohort study
    Baek, Ji Woo
    Yang, Yeun Soo
    Jung, Keum Ji
    Kimm, Heejin
    Kim, So Young
    Lee, Sunmi
    Jee, Sun Ha
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2024, 34 (12) : 2623 - 2629
  • [27] Metabolic Dysfunction-Associated Steatotic Liver Disease: Pathogenetic Links to Cardiovascular Risk
    Ionescu, Vlad Alexandru
    Gheorghe, Gina
    Bacalbasa, Nicolae
    Diaconu, Camelia Cristina
    BIOMOLECULES, 2025, 15 (02)
  • [28] Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review
    Zheng, Haixiang
    Sechi, Leonardo Antonio
    Navarese, Eliano Pio
    Casu, Gavino
    Vidili, Gianpaolo
    CARDIOVASCULAR DIABETOLOGY, 2024, 23 (01)
  • [29] Increased risk of cancers in metabolic dysfunction-associated steatotic liver disease and MetALD
    Park, Yewan
    Jung, Jooyi
    Kim, Gi-Ae
    JOURNAL OF HEPATOLOGY, 2024, 80 : S468 - S468
  • [30] Concordance between metabolic dysfunction-associated steatotic liver disease and nonalcoholic fatty liver disease
    Suzuki, Keito
    Tamaki, Nobuharu
    Kurosaki, Masayuki
    Takahashi, Yuka
    Yamazaki, Yudai
    Uchihara, Naoki
    Tanaka, Yuki
    Miyamoto, Haruka
    Yamada, Michiko
    Keitoku, Taisei
    Okada, Risa
    Higuchi, Mayu
    Takaura, Kenta
    Tanaka, Shohei
    Maeyashiki, Chiaki
    Yasui, Yutaka
    Tsuchiya, Kaoru
    Nakanishi, Hiroyuki
    Izumi, Namiki
    HEPATOLOGY RESEARCH, 2024, 54 (06) : 600 - 605
12345